Autor der Publikation

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL, , , , , , , , , und 3 andere Autor(en). Blood, 104 (3): 634–641 (2004)Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials, , , , , , , , , und 10 andere Autor(en). Haematologica, 94 (11): 1569–1580 (2009)Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL, , , , , , , , , und 12 andere Autor(en). Blood, 116 (23): 4916–4925 (2010)A biological definition of Burkitt's Lymphoma from transcriptional and genomic profiling, , , , , , , , , und 25 andere Autor(en). The New England Journal of Medicine, 354 (23): 2419--2430 (2006)A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling, , , , , , , , , und 25 andere Autor(en). The New England journal of medicine, 354 (23): 2419–2430 (2006)MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma, , , , , , , , , und 10 andere Autor(en). Blood, 121 (12): 2253–2263 (2013)Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status, , , , , , , , , und 18 andere Autor(en). Genes, chromosomes & cancer, 48 (1): 39–54 (2009)MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas, , , , , , , , , und 5 andere Autor(en). British journal of haematology, 142 (5): 732–744 (2008)Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), , , , , , , , , und 16 andere Autor(en). The Lancet Oncology, 9 (2): 105–116 (2008)Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis, , , , , , , , , und 8 andere Autor(en). Haematologica, 95 (12): 2047–2055 (2010)